For decades, a diagnosis of glioblastoma an aggressive, hard-to-treat cancer in the brain has been a death sentence for patients.
Only 3% to 5% of people who are diagnosed with this type of brain tu… [read more]
Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors – CNN
